Extension of Time to File SOU

MUCINEX INSTASOOTHE

RB Health (US) LLC

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88901117
LAW OFFICE ASSIGNED LAW OFFICE 121
MARK SECTION
MARK http://uspto.report/TM/88901117/mark.png (stylized and/or with design)
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION (current)
NAME RB Health (US) LLC
MAILING ADDRESS 399 Interpace Parkway
CITY Parsippany
STATE New Jersey
ZIP/POSTAL CODE 07054
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME RB Health (US) LLC
MAILING ADDRESS 399 Interpace Parkway
CITY Parsippany
STATE New Jersey
ZIP/POSTAL CODE 07054
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
ATTORNEY INFORMATION (current)
NAME Mark Lerner, Esq.
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME DUANE MORRIS LLP
STREET 230 PARK AVENUE, SUITE 1130
CITY NEW YORK
STATE New York
POSTAL CODE 10169
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 212-404-8714
FAX 212 818-9606
EMAIL malerner@duanemorris.com
DOCKET/REFERENCE NUMBER S4888-00668
ATTORNEY INFORMATION (proposed)
NAME Mark Lerner, Esq.
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME DUANE MORRIS LLP
STREET 230 PARK AVENUE, SUITE 1130
CITY NEW YORK
STATE New York
POSTAL CODE 10169
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 212-404-8714
FAX 212 818-9606
EMAIL malerner@duanemorris.com
DOCKET/REFERENCE NUMBER S4888-00804
CORRESPONDENCE INFORMATION (current)
NAME Mark Lerner, Esq.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE malerner@duanemorris.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) trademarks@duanemorris.com
CORRESPONDENCE INFORMATION (proposed)
NAME Mark Lerner, Esq.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE malerner@duanemorris.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) trademarks@duanemorris.com
DOCKET/REFERENCE NUMBER S4888-00804
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds; allergy relief medication; antihistamines
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 10/20/2020
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /charlieeveritt/
SIGNATORY'S NAME Charlie Everitt
SIGNATORY'S POSITION Group Head of Brand Protection
DATE SIGNED 08/20/2021
SIGNATORY'S PHONE NUMBER 07408865200
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Mon Aug 23 12:54:35 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XXX-
20210823125435566990-8890
1117-781ed1ef11c2b7f879d6
de044965636808635d61f3d23
05f499e1d74f4533e9f45-DA-
54334205-2021081809590893
7641



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: MUCINEX INSTASOOTHE (stylized and/or with design, see http://uspto.report/TM/88901117/mark.png)
SERIAL NUMBER: 88901117

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: RB Health (US) LLC, having an address of
      399 Interpace Parkway
      Parsippany, New Jersey 07054
      United States
      Email: XXXX
Proposed: RB Health (US) LLC, having an address of
      399 Interpace Parkway
      Parsippany, New Jersey 07054
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 10/20/2020.

For International Class 005:
Current identification: Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds; allergy relief medication; antihistamines

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

The applicant's current Attorney Information:
      Mark Lerner, Esq.      DUANE MORRIS LLP

      230 PARK AVENUE, SUITE 1130
      NEW YORK, New York 10169
      United States
      Phone: 212-404-8714
      Fax: 212 818-9606
      The docket/reference number is S4888-00668
      Email: malerner@duanemorris.com


The applicant's proposed Attorney Information:
      Mark Lerner, Esq.      DUANE MORRIS LLP

      230 PARK AVENUE, SUITE 1130
      NEW YORK, New York 10169
      United States
      Phone: 212-404-8714
      Fax: 212 818-9606
      The docket/reference number is S4888-00804
      Email: malerner@duanemorris.com


Correspondence Information (current):
      Mark Lerner, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: malerner@duanemorris.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@duanemorris.com

Correspondence Information (proposed):
      Mark Lerner, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: malerner@duanemorris.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@duanemorris.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /charlieeveritt/      Date Signed: 08/20/2021
Signatory's Name: Charlie Everitt
Signatory's Position: Group Head of Brand Protection
Signatory's Phone: 07408865200
Signature method: Sent to third party for signature

Mailing Address:
   DUANE MORRIS LLP
   
   230 PARK AVENUE, SUITE 1130
   NEW YORK, New York 10169

PAYMENT: 88901117
PAYMENT DATE: 08/23/2021

Serial Number: 88901117
Internet Transmission Date: Mon Aug 23 12:54:35 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202108231254355
66990-88901117-781ed1ef11c2b7f879d6de044
965636808635d61f3d2305f499e1d74f4533e9f4
5-DA-54334205-20210818095908937641




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed